Sign In to Follow Application
View All Documents & Correspondence

Composition

Abstract: Hair treatment composition comprising a zinc-based antidandruff agent, a conazole fungicide and a cationic modified guar deposition polymer.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
08 November 2011
Publication Number
10/2012
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2017-07-24
Renewal Date

Applicants

HINDUSTAN UNILEVER LIMITED
HINDUSTAN LEVER HOUSE, 165-166 BACKBAY RECLAMATION, MUMBAI, 400 020, INDIA

Inventors

1. CHANG WANLIN
UNILEVER THAI TRADING LTD, 18 SCB PARK PLAZA TOWER, RATCHADAPISEK ROAD, JATUJAK, 10900, BANGKOK, CHINA
2. JAYASWAL AMIT
UNILEVER (CHINA) LIMITED SHANGHAI BRANCH, 66 LINXIN ROAD, LINKONG ECONOMIC DEVELOPMENT ZONE, CHANGNING DISTRICT, 200335, SHANGHAI, CHINA
3. LI ZHENG RONG
UNILEVER (CHINA) INVESTING COMPANY, 66 LINXIN ROAD, LINKONG ECONOMIC DEVELOPMENT ZONE, CHANGNING DISTRICT, 200335, SHANGHAI, CHINA
4. SAMRAN BUSARAPORN
UNILEVER THAI SERVICES LTD, 18 SCB PARK PLAZA TOWER 1, RATCHADAPISEK ROAD, JATUJAK, BANGKOK, 10900, THAILAND

Specification

FORM - 2
THE PATENTS ACT, 1970
(39 of 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)
COMPOSITON
HINDUSTAN UNILEVER LIMITED, a company incorporated under
the Indian Companies Act, 1913 and having its registered office
at 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India
The following specification particularly describes the invention and the manner in which it is to be performed

COMPOSITION
The present invention relates to a hair treatment composition comprising anti-dandruff agents and a cationic deposition polymer.
DE 101 11 288 (Wella) discloses a composition comprising climbazole, zinc pyrithione and Polyquatemium-10.
Despite the prior art there remains the need for improved anti-dandruff compositions.
Accordingly, the present invention provides a hair treatment composition comprising a zinc-based antidandruff agent, a conazole fungicide and a cationic modified guar deposition polymer,
Preferably, the zinc-based antidandruff agent is zinc pyrithione.
Preferably, the zinc-based antidandruff agent is present at from 0.01 to 2% wt. of the composition. More preferably it is present at from 0.5 to 1.5 and most preferably from 0.75 to 1.25% wt. of the composition.
Preferably, the conazole fungicide is selected from ketoconazole and climbazole.
Preferably, the conazole fungicide is present at from 0.01 to 2% wt. of the composition. More preferably it is present at from 0.025 to 0.75% wt. of the composition.
Such cationic deposition polymers may be a homopolymer or be formed from two or more types of monomers. The molecular weight of the polymer will generally be between 5 000 and 10 000 000 unified atomic mass units, typically at least 10 000

and preferably from 100 000 to 2 000 000. The polymers will have cationic nitrogen containing groups such as quaternary ammonium or protonated amino groups, or a mixture thereof. A suitable cationic deposition polymer is AQU D4051 a cationically-modified guar commercially available from Aqualon.
Preferably, the cationic deposition polymer is guar hydroxypropyl trimonium chloride.
It is highly preferred that compositions according to the invention should contain from 0.04% to 2% wt. of the composition cationic deposition polymer, more preferably from 0.05 to 0.5% wt. and most preferably from 0.08 to 0.25% by weight of the composition.
The composition according to the invention may be in any common product form used to treat hair. However, preferably, it is shampoo composition.
The composition according to the invention may comprise any of the ingredients commonly found in hair treatment compositions depending on the product Form.
For example, where the composition is a shampoo it will comprise at least one cleansing surfactant such as is commonly employed in shampoos. Where it is a composition which aims to provide conditioning benefit, whether as part of a shampoo composition or a dedicated conditioning composition it will comprise a conditioning active. Suitable conditioning actives include fatty alcohols, silicones and cationic surfactants.
EXAMPLE 1
The following formulation is an embodiment of the invention and is made by standard processes.

Ingredient
%wt.
Sodium Laureth Sulphate 14
Cocoamidopropyl betaine 1.6
Guar hydroxypropyl trimonium chloride* 0.2
Zinc Pyrithione 1.0
Climbazole 0.5
Zinc sulphate 0.1
Dimethicone 2.0
Perfume 0.7
Sodium chloride 0.5
Propylene G)ocol 1.0
Acrylic Acid polymer (Carbomer) 0.6
Polypropylene Glycol 0.1
Preservative 0.22
Preservative 0.09
Water To 100
* Jaguar C17

EXAMPLE 2
The following demonstrates the efficacy of climbazole in the presence of cationic guar and polyquaternium-10.

Test sample Cone. ZPTO ug/cm3 after one rinse (two rinses) S.D.
1 % ZPTO, 0.5% 15.51 (12.199) 1.35(1.456)
climbazole, 0.2% Jaguar
C17
1 % ZPTO, 0.5% 12.39(7.49) 1.11 (0.57)
climbazole, 0.2% PQ-10

CLAIMS
1. Hair treatment composition comprising a zinc-based antidandruff agent, a conazole fungicide and a cationic modified guar deposition polymer.
2. Composition according to claim 1 wherein the zinc-based antidandruff agent is zinc pyrithione.
3. Composition according to claim 1 or 2 wherein the conazole fungicide is selected from ketoconazole and climbazole.
4. Composition according to any preceding claim wherein the polymer is guar hydroxypropyl trimonium chloride.

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 2340-MUMNP-2011-FORM 3( 10-12-2013).pdf 2013-12-10
1 2340-MUMNP-2011-FORM-27 [28-08-2024(online)].pdf 2024-08-28
2 2340-MUMNP-2011-FORM 3(10-11-2014).pdf 2014-11-10
2 2340-MUMNP-2011-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29
3 2340-MUMNP-2011-RELEVANT DOCUMENTS [14-09-2022(online)].pdf 2022-09-14
3 2340-MUMNP-2011-FORM 3-(25-04-2015).pdf 2015-04-25
4 2340-MUMNP-2011-FORM 3-(19-03-2016).pdf 2016-03-19
4 2340-MUMNP-2011-CLAIMS.pdf 2018-08-10
5 2340-MUMNP-2011-REPLY TO EXAMINATION REPORT-(25-04-2016).pdf 2016-04-25
5 2340-MUMNP-2011-CORRESPONDENCE(29-3-2012).pdf 2018-08-10
6 2340-MUMNP-2011-GENERAL POWER OF ATTORNEY-(25-04-2016).pdf 2016-04-25
6 2340-MUMNP-2011-CORRESPONDENCE(5-4-2013).pdf 2018-08-10
7 2340-MUMNP-2011-FORM 2(TITLE PAGE)-(25-04-2016).pdf 2016-04-25
7 2340-MUMNP-2011-CORRESPONDENCE.pdf 2018-08-10
8 2340-MUMNP-2011-FORM 1-(25-04-2016).pdf 2016-04-25
8 2340-MUMNP-2011-DESCRIPTION(COMPLETE).pdf 2018-08-10
9 2340-MUMNP-2011-CLAIMS(MARKED COPY)-(25-04-2016).pdf 2016-04-25
9 2340-MUMNP-2011-Examination Report Reply Recieved-090915.pdf 2018-08-10
10 2340-MUMNP-2011-CLAIMS(AMENDED)-(25-04-2016).pdf 2016-04-25
10 2340-MUMNP-2011-FORM 1.pdf 2018-08-10
11 2340-MUMNP-2011-ASSIGNMENT-(25-04-2016).pdf 2016-04-25
11 2340-MUMNP-2011-FORM 13(14-2-2012).pdf 2018-08-10
12 2340-MUMNP-2011-AFFIDAVIT--(25-04-2016).pdf 2016-04-25
12 2340-MUMNP-2011-FORM 18(29-3-2012).pdf 2018-08-10
13 2340-MUMNP-2011-AFFIDAVIT-(25-04-2016).pdf 2016-04-25
13 2340-MUMNP-2011-FORM 2(TITLE PAGE).pdf 2018-08-10
14 2340-MUMNP-2011-FORM 2.pdf 2018-08-10
14 Other Document [22-05-2017(online)].pdf 2017-05-22
15 2340-MUMNP-2011-FORM 3(15-2-2012).pdf 2018-08-10
15 Form 26 [22-05-2017(online)].pdf 2017-05-22
16 2340-MUMNP-2011-FORM 3(22-5-2014).pdf 2018-08-10
16 Form 13 [22-05-2017(online)].pdf 2017-05-22
17 2340-MUMNP-2011-ORIGINAL UNDER RULE 6 (1A)-30-05-2017.pdf 2017-05-30
17 2340-MUMNP-2011-FORM 3(22-6-2013).pdf 2018-08-10
18 2340-MUMNP-2011-FORM 3(23-1-2013).pdf 2018-08-10
18 Other Document [19-06-2017(online)].pdf 2017-06-19
19 2340-MUMNP-2011-FORM 3(8-8-2012).pdf 2018-08-10
19 2340-MUMNP-2011-FORM 3-18-07-2017.pdf 2017-07-18
20 2340-MUMNP-2011-Form 3-091015.pdf 2018-08-10
20 2340-MUMNP-2011-PatentCertificate24-07-2017.pdf 2017-07-24
21 2340-MUMNP-2011-Form 3-160816.pdf 2018-08-10
21 2340-MUMNP-2011_EXAMREPORT.pdf 2018-08-10
22 2340-MUMNP-2011-FORM 3.pdf 2018-08-10
22 2340-MUMNP-2011-WO INTERNATIONAL PUBLICATION REPORT A2.pdf 2018-08-10
23 2340-MUMNP-2011-FORM 5.pdf 2018-08-10
23 2340-MUMNP-2011-PatentCertificateCoverLetter.pdf 2018-08-10
24 2340-MUMNP-2011-OTHERS-090915.pdf 2018-08-10
24 2340-MUMNP-2011-FORM PCT-ISA-237.pdf 2018-08-10
25 2340-MUMNP-2011-HearingNoticeLetter.pdf 2018-08-10
25 2340-MUMNP-2011-Original Under Rule 6(1 A)Form 3-270117.pdf 2018-08-10
26 2340-MUMNP-2011-HearingNoticeLetter.pdf 2018-08-10
26 2340-MUMNP-2011-Original Under Rule 6(1 A)Form 3-270117.pdf 2018-08-10
27 2340-MUMNP-2011-FORM PCT-ISA-237.pdf 2018-08-10
27 2340-MUMNP-2011-OTHERS-090915.pdf 2018-08-10
28 2340-MUMNP-2011-FORM 5.pdf 2018-08-10
28 2340-MUMNP-2011-PatentCertificateCoverLetter.pdf 2018-08-10
29 2340-MUMNP-2011-FORM 3.pdf 2018-08-10
29 2340-MUMNP-2011-WO INTERNATIONAL PUBLICATION REPORT A2.pdf 2018-08-10
30 2340-MUMNP-2011-Form 3-160816.pdf 2018-08-10
30 2340-MUMNP-2011_EXAMREPORT.pdf 2018-08-10
31 2340-MUMNP-2011-Form 3-091015.pdf 2018-08-10
31 2340-MUMNP-2011-PatentCertificate24-07-2017.pdf 2017-07-24
32 2340-MUMNP-2011-FORM 3(8-8-2012).pdf 2018-08-10
32 2340-MUMNP-2011-FORM 3-18-07-2017.pdf 2017-07-18
33 2340-MUMNP-2011-FORM 3(23-1-2013).pdf 2018-08-10
33 Other Document [19-06-2017(online)].pdf 2017-06-19
34 2340-MUMNP-2011-FORM 3(22-6-2013).pdf 2018-08-10
34 2340-MUMNP-2011-ORIGINAL UNDER RULE 6 (1A)-30-05-2017.pdf 2017-05-30
35 Form 13 [22-05-2017(online)].pdf 2017-05-22
35 2340-MUMNP-2011-FORM 3(22-5-2014).pdf 2018-08-10
36 2340-MUMNP-2011-FORM 3(15-2-2012).pdf 2018-08-10
36 Form 26 [22-05-2017(online)].pdf 2017-05-22
37 2340-MUMNP-2011-FORM 2.pdf 2018-08-10
37 Other Document [22-05-2017(online)].pdf 2017-05-22
38 2340-MUMNP-2011-AFFIDAVIT-(25-04-2016).pdf 2016-04-25
38 2340-MUMNP-2011-FORM 2(TITLE PAGE).pdf 2018-08-10
39 2340-MUMNP-2011-AFFIDAVIT--(25-04-2016).pdf 2016-04-25
39 2340-MUMNP-2011-FORM 18(29-3-2012).pdf 2018-08-10
40 2340-MUMNP-2011-ASSIGNMENT-(25-04-2016).pdf 2016-04-25
40 2340-MUMNP-2011-FORM 13(14-2-2012).pdf 2018-08-10
41 2340-MUMNP-2011-CLAIMS(AMENDED)-(25-04-2016).pdf 2016-04-25
41 2340-MUMNP-2011-FORM 1.pdf 2018-08-10
42 2340-MUMNP-2011-CLAIMS(MARKED COPY)-(25-04-2016).pdf 2016-04-25
42 2340-MUMNP-2011-Examination Report Reply Recieved-090915.pdf 2018-08-10
43 2340-MUMNP-2011-DESCRIPTION(COMPLETE).pdf 2018-08-10
43 2340-MUMNP-2011-FORM 1-(25-04-2016).pdf 2016-04-25
44 2340-MUMNP-2011-CORRESPONDENCE.pdf 2018-08-10
44 2340-MUMNP-2011-FORM 2(TITLE PAGE)-(25-04-2016).pdf 2016-04-25
45 2340-MUMNP-2011-GENERAL POWER OF ATTORNEY-(25-04-2016).pdf 2016-04-25
45 2340-MUMNP-2011-CORRESPONDENCE(5-4-2013).pdf 2018-08-10
46 2340-MUMNP-2011-REPLY TO EXAMINATION REPORT-(25-04-2016).pdf 2016-04-25
46 2340-MUMNP-2011-CORRESPONDENCE(29-3-2012).pdf 2018-08-10
47 2340-MUMNP-2011-FORM 3-(19-03-2016).pdf 2016-03-19
47 2340-MUMNP-2011-CLAIMS.pdf 2018-08-10
48 2340-MUMNP-2011-RELEVANT DOCUMENTS [14-09-2022(online)].pdf 2022-09-14
48 2340-MUMNP-2011-FORM 3-(25-04-2015).pdf 2015-04-25
49 2340-MUMNP-2011-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29
49 2340-MUMNP-2011-FORM 3(10-11-2014).pdf 2014-11-10
50 2340-MUMNP-2011-FORM 3( 10-12-2013).pdf 2013-12-10
50 2340-MUMNP-2011-FORM-27 [28-08-2024(online)].pdf 2024-08-28

ERegister / Renewals

3rd: 29 Jul 2017

From 12/04/2012 - To 12/04/2013

4th: 29 Jul 2017

From 12/04/2013 - To 12/04/2014

5th: 29 Jul 2017

From 12/04/2014 - To 12/04/2015

6th: 29 Jul 2017

From 12/04/2015 - To 12/04/2016

7th: 29 Jul 2017

From 12/04/2016 - To 12/04/2017

8th: 29 Jul 2017

From 12/04/2017 - To 12/04/2018

9th: 10 Apr 2018

From 12/04/2018 - To 12/04/2019

10th: 02 Mar 2019

From 12/04/2019 - To 12/04/2020

11th: 02 Apr 2020

From 12/04/2020 - To 12/04/2021

12th: 05 Apr 2021

From 12/04/2021 - To 12/04/2022

13th: 12 Apr 2022

From 12/04/2022 - To 12/04/2023

14th: 05 Apr 2023

From 12/04/2023 - To 12/04/2024

15th: 06 Apr 2024

From 12/04/2024 - To 12/04/2025

16th: 03 Apr 2025

From 12/04/2025 - To 12/04/2026